Ausgabe 3/2018
Inhalt (26 Artikel)
Interventions are needed to support patient–provider decision-making for DCIS: a scoping review
Claire Kim, Laurel Liang, Frances C. Wright, Nicole J. Look Hong, Gary Groot, Lucy Helyer, Pamela Meiers, May Lynn Quan, Robin Urquhart, Rebecca Warburton, Anna R. Gagliardi
Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma
K. M. H. Vangangelt, G. W. van Pelt, C. C. Engels, H. Putter, G. J. Liefers, V. T. H. B. M. Smit, R. A. E. M. Tollenaar, P. J. K. Kuppen, W. E. Mesker
Functional transcriptomic annotation and protein–protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer
Miriam Nuncia-Cantarero, Sandra Martinez-Canales, Fernando Andrés-Pretel, Gabriel Santpere, Alberto Ocaña, Eva Maria Galan-Moya
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer
Melinda L. Telli, Jessica Hellyer, William Audeh, Kristin C. Jensen, Shikha Bose, Kirsten M. Timms, Alexander Gutin, Victor Abkevich, Rebecca N. Peterson, Chris Neff, Elisha Hughes, Zaina Sangale, Joshua Jones, Anne-Renee Hartman, Pei-Jen Chang, Shaveta Vinayak, Richard Wenstrup, James M. Ford
Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)
Noam Ponde, Ian Bradbury, Matteo Lambertini, Michael Ewer, Christine Campbell, Helene Ameels, Dimitrios Zardavas, Serena Di Cosimo, José Baselga, Jens Huober, Miguel Izquierdo, Debora Fumagalli, Ivana Bozovic-Spasojevic, Marion Maetens, Nadia Harbeck, Lajos Pusztai, Michael Berghorn, Young-Hyuck Im, Manuel Ruiz Borrego, Dar-Ren Chen, Richard Rodeheffer, Martine Piccart, Thomas Suter, Evandro de Azambuja
Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer
Tufia C. Haddad, Antonino D’Assoro, Vera Suman, Mateusz Opyrchal, Prema Peethambaram, Minetta C. Liu, Matthew P. Goetz, James N. Ingle
Observation versus excision of lobular neoplasia on core needle biopsy of the breast
Hank Schmidt, Brittany Arditi, Margaux Wooster, Christina Weltz, Laurie Margolies, Ira Bleiweiss, Elisa Port, Shabnam Jaffer
Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer
Annelie Liljegren, Anna von Wachenfeldt, Edward Azavedo, Sandra Eloranta, Helene Grundström, Anne Kinhult Ståhlbom, Ann Sundbom, Per Sundén, Gunilla Svane, Dieter Ulitzsch, Brita Arver
Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study
Yiqi Pan, Sarah R. Heisig, Pia von Blanckenburg, Ute-Susann Albert, Peyman Hadji, Winfried Rief, Yvonne Nestoriuc
Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival
Ying Zhang, Yajie Ji, Jianwei Li, Li Lei, Siyu Wu, Wenjia Zuo, Xiaoqing Jia, Yujie Wang, Miao Mo, Na Zhang, Zhenzhou Shen, Jiong Wu, Zhimin Shao, Guangyu Liu
Mammography use among women aged 18–39 years in the United States
Jin Qin, Mary C. White, Susan A. Sabatino, Isaedmarie Febo-Vázquez
High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
Al-Joharah Alhuqail, Areej Alzahrani, Hannah Almubarak, Sarah Al-Qadheeb, Lamyaa Alghofaili, Nisreen Almoghrabi, Hamed Alhussaini, Ben Ho Park, Dilek Colak, Bedri Karakas
Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry
Shengfeng Wang, Frank Qian, Yonglan Zheng, Temidayo Ogundiran, Oladosu Ojengbede, Wei Zheng, William Blot, Katherine L. Nathanson, Anselm Hennis, Barbara Nemesure, Stefan Ambs, Olufunmilayo I. Olopade, Dezheng Huo
Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study
Jung-Woo Chae, Peh Siang Chua, Terence Ng, Angie Hui Ling Yeo, Maung Shwe, Yan Xiang Gan, Sreemanee Dorajoo, Koon Mian Foo, Kiley Wei-Jen Loh, Si-Lin Koo, Wen Yee Chay, Tira Jing Ying Tan, Sok Yuen Beh, Elaine Hsuen Lim, Guek Eng Lee, Rebecca Dent, Yoon Sim Yap, Raymond Ng, Han Kiat Ho, Alexandre Chan
The impact of obesity on outcomes for patients undergoing mastectomy using the ACS-NSQIP data set
Mary Garland, Fang-Chi Hsu, Clancy Clark, Akiko Chiba, Marissa Howard-McNatt
Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States
Philip D. Poorvu, Ines Vaz-Luis, Rachel A. Freedman, Nancy U. Lin, William T. Barry, Eric P. Winer, Michael J. Hassett
Breast conserving surgery in combination with intraoperative radiotherapy after previous external beam therapy: an option to avoid mastectomy
F. Thangarajah, J. Heilmann, W. Malter, S. Kunze, S. Marnitz, P. Mallmann, F. Wenz, E. Sperk
BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia
Milena Jakimovska, Ivana Maleva Kostovska, Katerina Popovska-Jankovic, Katerina Kubelka-Sabit, Mitko Karadjozov, Liljana Stojanovska, Andreja Arsovski, Snezhana Smichkoska, Emilija Lazarova, Maja Jakimovska Dimitrovska, Dijana Plaseska-Karanfilska
Late breast cancer treatment-related symptoms and functioning: associations with physical activity adoption and maintenance during a lifestyle intervention for rural survivors
Tera L. Fazzino, Jennifer Klemp, Christie Befort
Long-term use of basal insulin and the risk of breast cancer
Karel Kostev, Matthias Kalder
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer?
Sara Bravaccini, Andrea Rocca, Giuseppe Bronte
Comment on a meta-analysis evaluating the cardiac toxicity of lapatinib in patients with breast cancer and other HER2-positive cancers
Qixing Tan, Changyuan Wei
Consideration of population and cultural factors in American Indian/Alaskan Native (AIAN) research
Susanna N. Basappa
How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer?
Matteo Lambertini, Caterina Fontanella